Home » Market News » DirectorsTalk Highlights » Numis Securities interview with Exscientia
Frontier IP Group Plc

Numis Securities interview with Exscientia

Numis’ Stefan Hamill spoke with Mark Swindells, Chief Operating Officer of Exscientia at this year’s Numis T500 Conference.

 

Exscientia develops a platform and automates drug discovery, and design using artificial intelligence-based (AI) technologies. Its compounds developed by AI systems balance potency, selectivity, and pharmacokinetic criteria in order to deliver efficacy. 

As at 30 June 2016, Frontier IP Group Plc have a 5% holding in Exscientia Limited.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.